Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

[Leprosy epidemiology in Daoukro health district (Côte d'Ivoire) from 1999 to 2017].

Tetchi E, Konan Y, Kpebo D, et al. Medecine tropicale et sante internationale. 2023; 3 (4) : 1-7.
Download PDF
Publication

Community based integrated wound care: Results of a pilot formative research conducted in Benin and Côte d’Ivoire, West Africa

Wadagni ACA, Yao TAK, Diez G, et al. Public Library of Science (PLoS). PLOS Global Public Health. 2024; 4 (2) : 1-20.
Download PDF
Publication

An mHealth App (eSkinHealth) for Detecting and Managing Skin Diseases in Resource-Limited Settings: Mixed Methods Pilot Study

Yotsu RR, Almamy D, Vagamon B, et al. JMIR Publications Inc.. JMIR Dermatology. 2023;
Download PDF
Practical material

"eSkinHealth" app

2023;
Access resource
Publication

Community-based wound management in a rural setting of Côte d'Ivoire.

Toppino S, Koffi D, Kone B, et al. PLoS neglected tropical diseases. 2022; 16 (10) : e0010730.
Download PDF
Publication

First cases of Mycobacterium leprae (Hansen’s disease) detection in Côte d’Ivoire using molecular diagnosis (PCR)

N’Golo David C, Christiane AA, Henry K, et al. Lepra. Leprosy Review. 2021; 92 (4) : 406-411.
Download PDF
Publication

Leprosy in wild chimpanzees.

Hockings K, Mubemba B, Avanzi C, et al. Nature. 2021;
Download PDF
Publication

Drugs Susceptibility Testing in Leprosy Patients from Côte d’Ivoire Reveals Multidrugs Resistance Combination Cases to Dapsone, Rifampicin and Ofloxacin

N’Golo David C, Roger DB, Kakou-N’Gazoa S, et al. American Journal of Microbiological Research. 2020; 8 (4) : 160-163.
Download PDF
Publication

Impact of common skin diseases on children in rural Cote d'ivoire with leprosy and buruli ulcer co-endemicity: A mixed methods study.

Yotsu RR, Comoé C, Germaine A, et al. PLoS neglected tropical diseases. 2020; 14 (5) : e0008291.
Download PDF
Publication

Integrated approach in the control and management of skin neglected tropical diseases in three health districts of Côte d'Ivoire.

Koffi A, Yao T, Barogui YT, et al. BMC public health. 2020; 20 (1) : 517.
Download PDF
Subscribe to Ivory Coast

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2025 InfoNTD